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Abstract
Heterologous overexpression of functional membrane proteins is a major bottleneck of
structural biology. Bacteriorhodopsin from Halobium salinarum (bR) is a striking example of
the difficulties in membrane protein overexpression. We suggest a general approach with a
finite number of steps which allows one to localize the underlying problem of poor expres-
sion of a membrane protein using bR as an example. Our approach is based on construct-
ing chimeric proteins comprising parts of a protein of interest and complementary parts of a
homologous protein demonstrating advantageous expression. This complementary protein
approach allowed us to increase bR expression by two orders of magnitude through the in-
troduction of two silent mutations into bR coding DNA. For the first time the high quality crys-
tals of bR expressed in E. Coli were obtained using the produced protein. The crystals
obtained with in meso nanovolume crystallization diffracted to 1.67 Å.
Introduction
The membrane protein (MP) genes comprise about one third of the human genes encoding pro-
teins. In spite of the recent success with GPCRs [1, 2], membrane proteins (MPs) still only com-
prise about 1% of total structures in the PDB [3, 4]. One of the bottlenecks in structural biology
for MPs is the difficulty of production of pure and functional MPs, especially of human origin.
However even bacterial and archea MPs often do not express heterologously. One of the striking
examples is the expression of bacteriorhodopsin fromHalobium salinarum (bR) in E. coli.
Bacteriorhodopsin is a light-driven pump that provides proton vectorial transport across
the cell membrane of the archaea [5, 6]. It consists of 7 transmembrane α-helices (7TM) with
the retinal molecule bound covalently to the Lys 216 residue [7] and belongs to the 7TM
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protein superfamily. As part of one of the simplest energy production mechanisms in the cell,
bR is of great interest for bioenergetics. Due to the high level of homologous expression, com-
bined with the ease of purification from the natural source [8] and high thermal and chemical
stability [9] this protein has become the most studied MP. BR is a widely used model for ex-
pression, folding, crystallization of MPs and X-ray crystallography. Highly ordered 3D crystals
of bR [10, 11] significantly improved understanding of the molecular mechanism of MP func-
tion and of vectorial proton transport in particular [12]. This protein and its mutants are in
high demand in studies regarding their applications in bioelectronics, optics, and optogenetics
[13–15]. Unfortunately, homologous production of bR mutants and many other light-driven
proteins is laborous, time- and resource-consuming or is simply not possible at all.
The bR functional expression in E. coli would be ideal as it is the most simple, robust, and
inexpensive system [16]. However, for almost 30 years continued efforts towards this goal have
been unsuccessful. The first studies showed a low level of wild type bR expression in E. coli due
to severe degradation of the newly synthesized protein [17, 18]. Application of exogenous N-
terminal tags has been used to stabilize the protein and prevent its degradation thereby increas-
ing the bR yield to 17 mg of protein per litre of culture [18, 19]. Further improvements in yield
were from the use of fusion proteins giving expression of 100–200 mg/l [20–22]. However, de-
spite the high yield the above mentioned systems did not result in functional bR expression re-
quiring refolding of the purified protein. Such behavior of bR is surprising, as a number of
closely related retinal proteins were expressed in a functional form in E. coli, namely halorho-
dopsin and sensory rhodopsin II from Natronomonas pharaonis (hR and SRII, respectively)
[23, 24], rhodopsin from Exiguobacterium sibiricum (ESR) [25], deltarhodopsin fromHaloter-
rigena turkmenica [26], and bacteriorhodopsin from Haloarcula marismortui [27].
This raises the questions why are the other 7TM retinal proteins readily overexpressed in E.
coli and why is bR not? What is the difference between bR and SRII that allows functional ex-
pression of SRII in E. coli? We addressed these questions by applying the complementary pro-
tein approach (CPA, shown in Fig 1). Chimeric proteins were constructed which comprised a
part of bR and a complementary part of a reference protein SRII. SRII was chosen as this retinal
protein was expressed functionally in E. coli [23, 24] and has high sequence identity to bR
(27.49%) plus the high resolution 3D crystal structure is available [28, 29]. This approach al-
lowed us to localize quickly the reason for the lack of bR expression in E. coli and we suggest
that it may have a general application.
Results
Identification of the part of bacteriorhodopsin amino acid sequence
responsible for failure of its expression in E. coli and strong influence of
positively charged Arg7 at N-terminus
We constructed chimeric proteins by combining complementary parts of bR and SRII (Fig 2).
The names of chimeric proteins indicate the complementary residues which have been replaced
in subscript. For example, we replaced the initial 43 amino acids of bR by the corresponding 36
amino acids of SRII to make chimeric protein SR1-37bRΔ(0–43). To elucidate the influence of ex-
tracellular, transmembrane and cytoplasmic regions independently we constructed SR1-8bRΔ(0–
9), SR26-37bRΔ(28–43), SR1-8,26-37bRΔ(0–9,28–43), respectively (Fig 2). The proteins were expressed
in E. coli, solubilized and purified from membranes isolated by ultracentrifugation using metal
affinity chromatography under denaturing conditions. Identity of the purified proteins was
confirmed by Western blotting with anti-His-tag antibodies. Replacement of the first 9 amino
acids on the N-terminus of bR by the counterparts from SRII significantly improves the expres-
sion of the native bR gene (Fig 3). The yields of SR1-8bRΔ(0–9) and the native bR were quantified
H. salinarum Bacteriorhodopsin Production in E. coli
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by a BCA protein assay as 7.0±1.0 and 0.14±0.04 mg/l, respectively. The yield of chimeric pro-
tein is comparable with that of the native bR in Halobium salinarum (30 mg/litre of culture,
[8]) and sufficient for structural studies and other purposes. Both chimeric proteins SR1-8bRΔ
(0–9) and SR1-37bRΔ(0–43) purified under non-denaturing conditions were not functional, but
were renaturated using an established procedure of bR retinalization in DMPC/CHAPS mi-
celles [30]. The reverse construct bR0-9SRΔ(1–8) containing the first 10 amino acids of bR in-
stead of their counterparts on the N-terminus of SRII (Fig 2) yielded 6.0±1.8 mg/l comparing
to 18.1±2.8 mg/l for SRII.
The point mutants R7Q and R7E eliminating the only positive charge on extracellularN-ter-
minus that do not satisfy “positive inside” rule were expressed and purified following the dena-
turing protocol with the yields of 0.96±0.20 mg and 0.37±0.10 mg of protein per litre of
culture, respectively (Fig 3), which are correspondingly 7 and 3 times higher than that for the
native bR but still 7 times lower than for a chimeric gene SR1-8bRΔ(0–9).
Optimization of mRNA remarkably increases the yield of wild type
bacteriorhodopsin
Using the mRNA structure prediction softwaremRNAshapes [31] we found a putative stem
structure at the start of the bR gene (Fig 4). As the stem stretches beyond nucleotide 37, we had
to expand the region under consideration to (-4, +47) comparing to the previous study [32]. This
region corresponds to amino acids fromMet0 to Leu15. The free folding energy of mRNA for
the (-4, +47) region of bR is predicted to be -22.4 kcal/mol (Fig 4), while the corresponding value
for SRII, ESR, and hR genes are -12.3, -5.2, and -13.1 kcal/mol respectively, indicating the de-
creased stability of the mRNA structures at the 5'-terminus near the ribosome binding site. The
change of the first 9 codons of bR to the counterparts of SRII considerably weakened the interac-
tions between the 6–15 and 33–41 regions of this stem and increased the free energy by 13.0
Fig 1. Representation of the complementary protein approach. Two homologous MPs reference protein (blue) and target protein (red) which have high
and low (or zero) expression in a selected organism respectively. One can construct chimeric proteins (1st iteration) comprising parts of the target protein and
the reference protein. Analyzing expression yields of the chimeric proteins one can determine which part of the target protein is responsible for a
heterologous expression failure. In the next step, one can divide this part of the protein and construct the next chimeric proteins (2nd iteration). Acting in the
samemanner one can finally localize the problem of the lack of high yield expression of the target protein (showed as blue star) in a limited number of steps.
One can estimate the required number of genetic constructs as 2log2N instead of 2N point mutations in the case of a random search for the problematic parts
of a protein responsible for the failure of the expression, where N is the number of amino acids in the target protein.
doi:10.1371/journal.pone.0128390.g001
H. salinarum Bacteriorhodopsin Production in E. coli
PLOSONE | DOI:10.1371/journal.pone.0128390 June 5, 2015 3 / 16
kcal/mol. Conversely, the folding energy of bR0-9SRΔ(1–8) is -15.5 kcal/mol which accounts for the
lower yield of this chimera. Since the expression levels of the native bR, SRII, SR1-8bRΔ(0–9), and
bR0-9SRΔ(1–8) correlated with the stability of the (-4, +47) region of mRNA structure, we intro-
duced into the wild type bR gene two silent mutations (C9A, G12A corresponding to amino
acids Ala2 and Gln3) that increase the free energy by 6.2 kcal/mol and significantly reduce the
Fig 2. Design of chimeric proteins between bR and SRII. N-terminus, first α-helix and the beginning of the second α-helix of bR (purple) and SRII (orange)
with the corresponding amino acid sequence are shown. Subscript in the name of the construct indicates amino acids of bR that were replaced by the
counterparts from SRII and vice versa.
doi:10.1371/journal.pone.0128390.g002
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Fig 3. SDS-PAGE analysis of chimeric proteins, point mutants purified bymetal affinity chromatography under denaturing conditions. A.
coomassie-stained gels. B. corresponding anti-His-tag antibody stained imunoblots. The amount of the protein loaded was normalized to the total amount of
cell culture. C. The yields of the chimeric proteins and point mutants as quantified by the BCA protein assay, band density on SDS-PAGE andWestern
blotting. Chimeric proteins containing extracellular N-terminus of SRII have shown a much better yield.
doi:10.1371/journal.pone.0128390.g003
Fig 4. ThemRNA shapes of the native bR, SRII, chimeric protein SR1-8bRΔ(0–9), and optimized bR gene. The region (-4, +47) with numbering starting
from ATG start codon is shown. This region corresponds to amino acids fromMet0 to Leu15. Free energies presented are expressed in kcal/mol. The values
of mRNA free energy for SRII and SR1-8bRΔ(0–9) are considerably smaller than those of the native bR gene. The mRNA structure optimization of bR by silent
mutations increased the free energy of the region (-4, +47) by 6.2 kcal/mol. The red arrows indicate the mutated nucleotides.
doi:10.1371/journal.pone.0128390.g004
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stem stability (Fig 4). The optimized bR gene was expressed in E. coli and purified following the
denaturing protocol. The yield of the protein in case of the optimized gene was quantified as 9.2
±3.5 mg per litre of culture, when measured by BCA protein assay, being essentially the same as
that of SR1-8bRΔ(0–9) (p = 0.74) in contrast to the low yield of native gene (Fig 3).
Purification and characterization of functional wild-type
bacteriorhodopsin under non-denaturing conditions
When we utilized a mild detergent for solubilization of E. colimembranes and the non-dena-
turing protocol for protein purification, bR expressed from the optimized gene retained its pur-
ple color. The first step of purification by metal affinity chromatography led to mixed
functional and nonfunctional bR preparations. The total yield of the protein after affinity puri-
fication was 7.6±2.9 mg per litre of culture, as measured by BCA protein assay. Sample homo-
geneity was confirmed by coomassie-stained SDS-PAGE.
As solubilized bR is unstable at alkaline pH and imidazole is harmful for the protein, we re-
moved imidazole and adjusted pH to 6.0 by dialysis. During the pH exchange the protein
heavily precipitated. The pellet was not colorled and constituted of bR according to SDS-PAGE
analysis suggesting aggregation of the misfolded protein. The pellet was discarded leaving the
functional bR in the supernatant, however UV-Vis spectroscopy showed that the sample still
contained aggregates and protein contaminants.
Further purification of bR utilised size-exclusion chromatography (SEC) yielding two dis-
tinct peaks at 69 ml and 86 ml corresponding to bR aggregates and functional bR respectively
(Fig 5). The colored fractions from the latter peak were pooled, mixed and concentrated. The
UV-Vis absorbance spectrum exhibited the retinal absorption peak at 555.5±1.0 nm. A peak
ratio at A280/Aλret of 1.5 was achieved (Fig 5), demonstrating that the purity of the protein is
consistent with that of bR solubilized from native purple membranes ofH. salinarum. Storage
stability of the protein was analysed 5 days after purification by repeat SEC on the same column.
Fig 5. Characterization of bR expressed in E. coli. A. Elution profile of the wild type bR on Sephacryl S200HR. The initial run is shown in red and the repeat
run (after storage) in blue. The peak at 68.68 ml in the first run corresponds to the aggregated colorless protein. The second peak at 85.54 ml is the functional
target protein. The fractions corresponding to the second peak were colored and those in the grey box were pooled. The repeat run after 5 days does not
show any significant amount of aggregates. B. UV-Vis absorption spectra of the samples of the wild type bR and D85N and D96Nmutants normalized by
absorbance at 280 nm. Proteins were solubilized in DDM and purified using non-denaturing protocol. The spectrum of the wild type bR exhibited the retinal
absorption peak at 555.5±1.0 nm with a peak ratio A280/Aλret of 1.5 which corresponds to the highest purity of bR.
doi:10.1371/journal.pone.0128390.g005
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Bacteriorhodopsin eluted as a single and symmetric (asymmetry index 1.05) peak indicating
size homogeneity of the final product. This confirmed that the aggregates were removed
completely from the samples and the purified protein had no tendency to denature or form ag-
gregates during storage. Prolonged storage indicated that the protein half-life at 4°C exceeds
120 days. The final yield of the purified functional wild type bR expressed in E. coli was 2.4±1.3
mg of the protein per litre of culture corresponding to 15–35% of the total synthesized bR.
Expression, functional purification, and characterization of D85N and
D96Nmutants of bacteriorhodopsin
Using the mRNA-optimized bR gene we have introduced mutations D85N and D96N and uti-
lizing the non-denaturing purification protocol we readily obtained functional mutant proteins
with the final yields of 3.8 and 8.8 mg per litre of culture, respectively. The mutant proteins had
essentially the same gel-filtration elution profiles as the wild-type bR. D96N UV-Vis spectrum
was simular to the wild-type bR, while D85N mutant exhibited the characteristic maximum
retinal absorbance for this protein at 598.0 nm (Fig 5).
Crystallization of the purified proteins
With the wild type bR, D85N and D96Nmutant proteins we set up nanovolume in meso crys-
tallization trials [10, 33] which yielded crystals within 5–10 days for all proteins. The crystals of
wild type protein and D96Nmutant had a shape of thin hexagonal plates of 120 μm (Fig 6).
The single crystals obtained without optimization were tested at a synchrotron beam line and
gave difraction up to 1.67 Å resolution (Fig 6). The structure was solved with a resolution of 1.9
Å (see Table 1 for Crystallographic data statistics) and deposited in the PDB with ID code of
4XXJ. The crystals belonged to the spacegroup C2 with three monomers in the asymmetric unit
that form a trimer. Typically for in meso crystallization, the protein molecules form membrane-
like layers, with purple membrane-like packing within the layer (Fig 7). Despite the absence of
nativeHalobacterium salinarum lipids, the intertrimer distance is essentially identical to that of
Fig 6. Crystals of bR D96Nmutant. A. Crystals of bR D96Nmutant expressed in E. coli were obtained using the in meso nanovolume crystallization
approach. The largest crystals had the size of 120 μm. B. A crystal (without further optimization of crystallization conditions) showed diffraction to 1.67 Å
(inset).
doi:10.1371/journal.pone.0128390.g006
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the crystals obtained with purple membrane-derived bacteriorhodopsin. The structure of the
protein and its trimer is also identical to that of purple membrane-derived bacteriorhodopsin
(Fig 7). Data reveal the essential features of the structure, including the retinal cofactor and the
hydrogen bond-linked cluster of water molecules close to the Schiff base (Fig 7).
Discussion
In spite of the high level of sequence identity bR did not show functional expression in E. coli
whereas to SRII, hR, and ESR did. To determine why this is the case we looked more coldly at
the differences in the amino acid sequences (Fig 8). The “positive inside” rule states that MP
topogenesis is controlled by positively charged amino acids [34] that keep the cytoplasmic
parts of MP in the cytoplasm. This is due to the interactions with negatively charged head-
groups of anionic lipids [35, 36] and these amino acids can therefore withstand both Sec-de-
pendent and Sec-independent translocation against membrane potential. As observed in vitro,
via the use of lysates and inner membrane vesicles (prepared from E. coli) bR is inserted co-
translationally into the E. colimembrane in a Sec-dependent manner [37] proving the amino
acid sequence of the first transmembrane helix and adjacent regions to be particularly impor-
tant for the insertion of integral MPs into membrane.
Table 1. Crystallographic data collection and refinement statistics.
Data collection
Space group C2
Cell dimensions
a, b, c (Å) 105.84, 60.76, 113.36
α, β, γ (°) 90, 99.78, 90
Resolution (Å) 49.2–1.9 (1.95–1.9)*
Rmerge (%) 7.1 (110.2)*
I/σI 13.7 (1.41)*
Completeness (%) 98.8 (98.3)*
Multiplicity 4.5 (4.5)*
Refinement
Resolution 49.2–1.9 Å
No. reflections 56113 (2796**)
Rwork / Rfree 18.35% / 21.39%
Number of atoms
Protein 5306
Retinal 60
Lipid 248
Water 90
Average B-factor (Å2)
Protein 34.4
Retinal 25.6
Lipid 51.2
Water 39.0
R.m.s. deviations
Bond lengths 0.005 Å
Bond angles 0.9°
* Values in parentheses are for the highest-resolution shell.
** Number of reflections that are not used for refinement (free reflections)
doi:10.1371/journal.pone.0128390.t001
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The alignment of bR, SRII, ESR, and hR revealed two distinct features of bacteriorhodopsin
in the region of the first transmembrane helix. First, the positively charged Arg7 on the extra-
cellular N-terminus of bacteriorhodopsin deviates from the "positive inside" rule. Second,
bacteriorhodopsin has a different positively charged amino acid pattern in the cytoplasmic
loop A-B, where lysines substitute for the arginines in the vicinity of the hydrophobic-hydro-
philic interface. Such a charge distribution on the membrane flanking regions of the first helix
may compromise the folding and expression rate of bR. Thus, this preliminary considerations
helped us to select the bR region that may contain parts of the protein problematic for E. coli
expression. To investigate whether the charge distribution in the helix A region influences bR
expression level in E. coli and the insertion of the protein into bacterial membrane we
Fig 7. Crystallographic structure of E. coli-expressed bacteriorhodopsin. A. Packing of E. coli-expressed bacteriorhodopsin in the C2 crystals (three
molecules per asymmetric unit). The inter-trimer distance is 60.76 Å. B. Packing of bacteriorhodopsin from purple membrane in the P63 crystals (one
molecules per asymmetric unit). The inter-trimer distance is 60.63 Å [11]. C Comparison of the trimer structure in the C2 (green) and P63 (yellow) crystals.
The structures are essentially identical with r.m.s.d. of the atom positions of less than 0.3 Å. D and E 2Fo-Fc electron densities around the retinal D and its
Schiff base E contoured at the level of 1.5 σ. Hydrogen bonds are shown in yellow.
doi:10.1371/journal.pone.0128390.g007
Fig 8. Sequence alignment of HR, ESR, SRII and bR amino acids of the helix A. Positively charged, negatively charged and hydrophobic amino acids
are marked with blue, red and green colors respectively. Transmembrane domains of helix A as determined from the structure are marked with light grey.
These specific features of bR, which may affect expression of the protein, were revealed in bR and are underlined.
doi:10.1371/journal.pone.0128390.g008
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constructed several chimeric proteins by combining complementary parts of bR and SRII (Fig
2), as the latter is expressed in E. coli functionally with a high yield [23] and satisfies the "posi-
tive inside" rule (Fig 8).
There are already literature data on the construction of chimeric proteins between homolo-
gous proteins to find, for example, amino acid residues determining functional differences be-
tween these homologs (e.g. [38]). Moreover, on occasions when the chimeric proteins have a
high expression yield or increased stability, they are expressed and even crystallized instead of
their ancestors [39]. However, the systematic studies of the reason for the E. coliMP expression
failure that involve the use of the chimeric proteins were lacking. Here, using bR as an example
we show how the described approach can be employed for efficient MP production. A gain of
over 50 times in the yield of bR expressed in E. coli was reached by the replacement of extracel-
lular N-terminus of bR with the SRII amino acid sequence. It should be stressed that the part of
the protein “responsible” for the failure of bR expression in E. coli was localized in 2 steps using
4 chimeric proteins. In general, CPA allows one to reduce the required number of genetic con-
structs from 2N point mutations to 2log2N chimeric proteins, where N is the number of amino
acids in the target protein.
Interestingly, the construct bR0-9SRΔ(1–8) containing the first 10 amino acids of bR instead
of their counterparts on the N-terminus of SRII (Fig 2) yielded 6.0±1.8 mg/l comparing to 18.1
±2.8 mg/l for SRII. Spectral tuning of SRII by constructing chimeric proteins between SRII and
bR [40] produced in small amount the functional chimera comprising A-C helices of bR and
D-G helices of SRII expressed in E. coli. In the case of the bR0-9SRΔ(1–8) construct under non-
denaturing conditions a functional protein was not obtained. We hypothesize that the intro-
duction of charged residues into the hydrophobic interface of helix A brakes its hydrophobic
interactions with the other helices leading to the destabilization of the SRII structure and thus
misfolding of the bR0-9SRΔ(1–8) chimera. Therefore, the suppressing influence of the extracellu-
lar N-terminus of bR has been supported by deterioration of functional SRII expression in E.
coli when the N-terminus of SRII was replaced with its counterpart from bR.
Since the low expression level of wild type bR in E. coli comparing to SR1-8bRΔ(0–9) could be
caused by the unfavorable mRNA structure of the bR gene near the ribosome binding site or
the presence of positively charged Arg7 at the N-terminus side of the helix A of bR, we studied
the influence of these two factors separately. First, we replaced Arg7 of the native bR gene by ei-
ther neutral or negatively charged residue and constructed mutants R7Q and R7E respectively.
The observed relationship between expression levels of native bR, R7Q and R7E mutants, and
the SR1-8bRΔ(0–9) chimera in E. coli (Fig 3) could be explained in part by the "positive inside"
rule as the removal of the positive charge on the N-terminus of bR improves the yield of the
protein. However, these experiments showed that it is not the only reason for the low expres-
sion level of bR in E. coli.
The stability of mRNA folding near the ribosome binding site is known to have a strong im-
pact on the protein expression level [32]. It has been shown that the variation of the nucleotide
sequence near the ribosome binding site significantly influences the expression level of bR in E.
coli, but functional incorporation of the protein into membrane has not been achieved [18].
Using the mRNA structure prediction softwaremRNAshapes [31] we found a putative stem
structure at the start of the bR gene. The optimized bR gene yielded essentially the same
amount of protein as the chimeric proteins in contrast to the native gene as demonstrated by
Fig 3. Thereby, we showed that destabilization of the putative stem structure in the 5'-terminus
of mRNA leads to a significant increase in the expression level of the protein.
The optimization of mRNA has also significantly increased the bR expression rate in the pre-
vious study with the use of pJP plasmid [18]. Additionally, in the mRNA 5' untranslated region
the hairpin structure was found. It encloses the lac operator and hence impairs mRNA
H. salinarum Bacteriorhodopsin Production in E. coli
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translation initiation [18], whereas in case of the pSCodon plasmid we have not observed any ad-
verse influence of the lac operator on the protein yield. This discrepancy could be explained by a
insufficient spacing between the lac operator and the ribosome binding site in the pJP plasmid.
The total yield of an unfolded bR was approximately 2 times lower than in the present study, be-
cause of a rapid degradation of the newly synthesized protein under the expression conditions.
Karnik et al. have shown that only 1–2% of bR synthesized in E. coli bound retinal, when
cells were incubated at 37°C after induction with IPTG [18]. We suppose that the main factor
that influences the yield of the functional bR in the case of E. coli expression may be the rate of
protein synthesis. Indeed, it is recommended to express MPs at lower temperatures (20–30°C)
to reduce the rate of the protein synthesis, facilitate its membrane insertion and proper folding
[41]. As shown in vitro bR insertion into membrane occurs co-translationally in a Sec-depen-
dent manner [37]. Its overexpression can overload the cell translocation system resulting in a
misfolded protein and an increased rate of protein degradation. Induction of protein synthesis
by lactose and cultivation of the cells at lowered temperature reduce the protein synthesis rate
and thus favour an accumulation of the properly folded protein. Using similar mutations to op-
timize mRNA structure (-16.2 vs. -12.3 kcal/mol) we obtained the doubled translational yield
of bR comparing to the previous study of Karnik et al. [18]. Since Karnik et al. employed a
denaturing protein purification protocol, they had to renature the protein using DMPC/
CHAPS vesicles, whereas our protocol takes advantage of non-denaturing conditions, thus al-
lowing a straightforward production of the functional protein. The high rate of bR misfolding
can also be attributed to an unfavorable lipid composition of the E. colimembrane. The PE lip-
ids, a major component of the E. colimembrane, were shown to decrease the bR regeneration
yield in vitro [42]. Also the folding of bR is described by a two-stage model with at least one
transition state [43]. Therefore, E. coli lipids appear to have a significant effect on the transition
state and favor bR misfolding.
Nevertheless, the protocol for high-yield bR production in E. coli introduced here allows
one to obtain functional protein under non-denaturing conditions in quantities sufficient for
structural biology and biochemical studies. Whereas other protocols require protein extraction
with organic solvents and solubilization of the protein in denaturing detergents followed by
protein renaturation as well as the necessity of the expression drivers [18–22]. bR obtained
using the presented protocol is stable, homogenious and resembles a native bR from purple
membranes, and thus satisfies the requirements for the use of this protein in different applica-
tions in science and industry.
One of the main advantages of the E. coli expression system over H. salinarum is the consid-
erably reduced time required to produce the mutants of interest facilitating intense studies of
the target protein. We proved that the suggested approach is also efficient for fast production
of bR mutants. Asp85 is primary proton acceptor and Asp96 is primary proton donor, there-
fore the D85N and D96N are the key mutants that are intensively used to trap the intermediate
states of bR. The higher expression level of D85N and D96N mutants compared to wild type
bR deserves additional attention. It has been previously reported that mutation D94N in the
bacteriorhodopsin fromHaloarcula marismortui (analogous to D96N in bR) raised 10-fold the
yield of the functional protein [44]. In addition, it was shown that insertion of the bR helix C
into membrane in vitro is impeded by two aspartic acid residues within its transmembrane re-
gion [45]. In the present work D85N and D96N mutations led to the 1.5 to 4-fold increase in
the yield of the functional protein relative to the wild type bR, the fraction of a properly folded
protein increased as well from 25±10% to 35% and 60% of the total transcriptional yield of
D85N and D96N mutants, respectively. This increase may be explained by improved incorpo-
ration of the newly synthesized protein into the E. colimembrane that reduces protein degrada-
tion and facilitates the correct folding of the bR mutants.
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The growth of the first highly ordered 3D crystals of bR expressed in E. coli and the similari-
ty of its structure to the structure of bR obtained from H. salinarum show the aptness of the
presented approach for the expression of bR and its mutants suitable for all scientific and in-
dustrial applications. Moreover, the obtained high-quality crystals of bR produced in E. coli
lacking native lipids of H. salinarum addresses a long-standing question in crystallization of
membrane proteins. Despite the role of native lipids for MP crystallization being considered
important, there is little information published on this matter [46]. Particularly, archea lipids
that stabilize bR molecules in the trimer inside the 2D and 3D crystals were assumed to be
highly specific [47, 48]. These findings were supporting the idea that native lipids of H. sali-
narum are required to form highly ordered bR crystals. Our work demonstrates that bR ex-
pressed in E. coli is readily crystallized by in meso approach and, therefore, native lipids
surrounding the protein are not an absolute requirement for growing well diffracting bR crys-
tals. Although we have demonstrated high efficiency of the CPA in the case of microbial rho-
dopsin family we believe that the CPA may be applied to other membrane proteins.
Materials and Methods
Materials
All the salts and media components were purchased either from AppliChem (Darmstadt, Ger-
many) or Sigma-Aldrich (Taufkirchen, Germany) of analytical quality or higher. All enzymes
were from Fermentas (part of Thermo Fisher Scientific, St. Leon-Rot, Germany). DDM was
from Affymetrix (Santa Clara, USA), Sarkosyl from AppliChem, retinal, DMPC, and CHAPS
from Sigma-Aldrich.
DNAmanipulations
The coding region of bR gene excluding the leader signal peptide sequence was amplified from
pEF191 plasmid kindly provided by D. Oesterhelt [49]. The factor Xa cleavage site and eight
histidine purification tag coding sequences were appended to the bR 3'-terminus using synthet-
ic oligonucleotides resulting in GSGIEGRSGAPHHHHHHHH extension. The obtained bR
gene was cloned into NdeI and XhoI sites of pSCodon vector (Delphi Genetics S.A., Charleroi,
Belgium). The pSOPII plasmid bearing the SRII gene in pET27bmod vector was provided kind-
ly by M. Engelhard [23]. All bR-SRII chimeric genes (Fig 2) and bR mutant genes were pro-
duced by PCR.
The mRNA folding energies were calculated usingmRNAshapes software [31]. Bacteriorho-
dopsin coding sequence was optimized by introducing two silent mutations C9A and G12A
corresponding to amino acids Ala2 and Gln3.
Protein expression and membrane isolation
E. coli SE1 [50] cells were transformed with pSCodon-derived plasmids, and E. coli BL21(DE3)
cells were transformed with pET27-derived plasmids. Cells were plated over LB-agar and then
grown in 450 ml rich ZYP-5052 autoinduction media [51] with an appropriate antibiotic in
buffled shaking 2-L flasks at 120 rpm. The cells were incubated at 37°C until OD600 reached
1.0–1.2 AU, when 400 μl of 50 mM all-trans retinal solution in ethanol was added, and cells
were further cultivated at 20°C. Cells from 1 litre of overnight culture were harvested by centri-
fugation at 5000 rpm, resuspended in 50 ml of 20 mM Tris-HCl pH 8.0, 5% glycerol, supple-
mented with 10 mg of lysozyme and 1 mg of DNAseI, and incubated for 2 h at 4°C with
stirring. Lysate was obtained by passing the suspension 3 times through micro-fluidizer M-
110P fromMicrofluidics (Westwood, USA). Then 5M NaCl was added to a final concentration
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of 200 mM and suspension was layered over a glycerol cushion (1 ml—90%, 1 ml—80%, 1ml—
60%) in two 32 ml tubes. The total membranes were isolated by ultracentrifugation in SW-
32Ti rotor (Beckman Coulter, Krefeld, Germany) at 28 000 rpm for 1h. The supernatant was
discarded and the glycerol cushion containing membranes was resuspended in 50 ml of 20 mM
Tris-HCl pH 8.0, 100 mMNaCl.
Denaturing protein purification
Sarkosyl was added to the final concentration of 2% and membranes were solubilized overnight
with stirring at 4°C. Insoluble material was removed by ultracentrifugation in Ti-70 (Beckman
Coulter) rotor at 35 000 rpm for 1h. Supernatant was 5 times diluted with 20 mM Tris-HCl pH
8.0, 100 mMNaCl buffer and 10 mM imidazole was added. Suspension was loaded on the 5 ml
of Ni-NTA resin (Qiagen, Hilden, Germany) equilibrated with the same buffer. The column
was first washed with 3 CV of 50 mM Tris-HCl pH 8.0, 100 mMNaCl, 0.25% Sarkosyl, 20 mM
imidazole buffer, then 5 CV of 100 mMNa2HPO4 pH 8.0, 100 mMNaCl, 0.2% SDS, and 3 CV
of 100 mMNa2HPO4 pH 8.0, 0.2% SDS buffer. The protein was eluted with 3 CV of 100 mM
Na2HPO4 pH 8.0, 0.2% SDS, 300 mM imidazole. To remove imidazole the samples were dia-
lysed against 0.8 L of 50 mMNaH2PO4 pH 6.0, 0.2% SDS. When necessary purified proteins
were refolded in mixed DMPC/CHAPS micelles [30]. Reliability of the protein yields compari-
son was estimated by Student's test and presented as p value.
Non-denaturing protein purification
DDMwas added to the final concentration of 1% and membranes were solubilized overnight
with stirring at 4°C. Insoluble material was removed by ultracentrifugation in Ti-70 rotor at 35
000 rpm for 1h. Supernatant was 5 times diluted with 20 mM Tris-HCl pH 8.0, 100 mMNaCl
buffer and 10 mM imidazole was added. Suspension was loaded on the 5 ml of Ni-NTA resin
equilibrated with the same buffer. The column was washed with 10 CV of 50 mMNaH2PO4
pH 6.0, 100 mMNaCl, 0.2% DDM, 30 mM imidazole. The protein was eluted with 3 CV of 50
mMNaH2PO4 pH 7.4, 100mMNaCl, 0.2% DDM, 300 mM imidazole. Only coloured fractions
were pooled. To remove imidazole the samples were immediately dialysed against 0.6 L of 50
mMNaH2PO4 pH 6.0, 100 mMNaCl for 2 hours and removed from dialysis buffer, then after
10 hours dialysis was continued for additional 2 hours against fresh buffer.
After the dialysis the protein heavily precipitated. The white pellet was separated by centrifu-
gation at 5000 rpm from colored solution and discarded. Protein was concentrated to the vol-
ume of 2 ml by ultrafiltration and applied to 165 ml Sephacryl S200HR (GE Healthcare,
Germany) column equilibrated with 50 mMNaH2PO4 pH 6.0, 100 mMNaCl, 0.1% DDM. Peak
of colored functional protein could be easily separated from the peak of the aggregated protein.
The samples were protected from the light. Total protein concentration was measured by
BCA Protein Assay Kit (Thermo Fisher Scientific, Schwerte, Germany) following supplier pro-
tocol. To access the protein purity the samples were analyzed on 8–16% gradient SDS-PAGE.
UV-Vis absorbance spectrum was measured on UV-2450 spectrophotometer (Shimadzu,
Duisburg, Germany). The fraction of the functional protein was accessed as absorbance ratio
A280/Aλret, where Aλret is maximum absorbance of retinal in the protein [52].
Crystallization, data collection, and structure determination
The crystals were grown using in meso approach using nanovolume robotic system Formula-
trix NT8 (Waltham, USA) [10, 33], similarly to our previous work [28, 53, 54]. The purified
protein in crystallization buffer was added to the monooleoyl-based lipid mesophase. The best
crystals were obtained using the protein concentration of 20 mg/ml and 1.5M Na/K-Pi pH 5.6
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precipitation solution. The crystals were grown at 22°C and reached 120 μm in size in approxi-
mately one week.
X-ray diffraction data (wavelength 0.976 Å) were collected at the beamline ID23-1 of the
European Synchrotron Radiation Facility (ESRF, Grenoble, France) using a PILATUS 6M de-
tector (Dectris Ltd., Baden, Switzerland). Diffraction patterns integrated using XDS and the re-
flexes’ intensities were scaled using and XSCALE [55], and the space group was determined to
be C2. The data statistics are presented in the Table 1. Initial phases were successfully obtained
in the space group C2 by molecular replacement method using MOLREP [56], with PDB ID
1C3W [11] as a search model. There are three monomers in the asymmetric unit in this space
group. The initial molecular replacement model was then iteratively refined using REFMAC5
[57] and Coot [58].
Accession numbers
The atomic coordinate and structure factors have been deposited in the PDB with ID code
4XXJ.
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